1. Home
  2. TMDX vs PCVX Comparison

TMDX vs PCVX Comparison

Compare TMDX & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$136.66

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$46.76

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMDX
PCVX
Founded
1998
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
6.0B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
TMDX
PCVX
Price
$136.66
$46.76
Analyst Decision
Buy
Strong Buy
Analyst Count
10
7
Target Price
$133.00
$101.67
AVG Volume (30 Days)
835.5K
1.5M
Earning Date
10-29-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
170.70
N/A
EPS
2.54
N/A
Revenue
$566,354,000.00
N/A
Revenue This Year
$38.84
N/A
Revenue Next Year
$20.43
N/A
P/E Ratio
$53.83
N/A
Revenue Growth
41.20
N/A
52 Week Low
$55.00
$27.66
52 Week High
$156.00
$94.60

Technical Indicators

Market Signals
Indicator
TMDX
PCVX
Relative Strength Index (RSI) 54.31 51.97
Support Level $133.50 $43.78
Resistance Level $156.00 $48.11
Average True Range (ATR) 8.50 1.99
MACD 0.41 -0.49
Stochastic Oscillator 55.98 42.99

Price Performance

Historical Comparison
TMDX
PCVX

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: